Patent | Date |
---|
Composition Of Lanosterol Prodrug Compound, Preparation Method Therefor And Use Thereof App 20220133744 - Liu; Yizhi ;   et al. | 2022-05-05 |
Compound For Use In Retinal Diseases App 20220127243 - LI; Peng ;   et al. | 2022-04-28 |
Process Route Of Compound Of Formula (iv), Crystal Form And Preparation Method Therefor App 20220024880 - LUO; Zhi ;   et al. | 2022-01-27 |
Method, apparatus, and device for processing web application package Grant 11,157,254 - Luo October 26, 2 | 2021-10-26 |
Crystal form of lanosterol prodrug compound and application thereof Grant 11,149,055 - Liu , et al. October 19, 2 | 2021-10-19 |
Crystal Form Of Lanosterol Prodrug Compound And Application Thereof App 20210246158 - LIU; Yizhi ;   et al. | 2021-08-12 |
Ssao Inhibitor App 20210198220 - LUO; Zhi ;   et al. | 2021-07-01 |
SSAO inhibitor Grant 11,001,563 - Luo , et al. May 11, 2 | 2021-05-11 |
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof Grant 10,981,860 - He , et al. April 20, 2 | 2021-04-20 |
Steroid Derivative FXR Agonist App 20210040140 - HE; Haiying ;   et al. | 2021-02-11 |
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,912,775 - Wu , et al. February 9, 2 | 2021-02-09 |
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,898,486 - Wu , et al. January 26, 2 | 2021-01-26 |
Steroid derivative FXR agonist Grant 10,875,888 - He , et al. December 29, 2 | 2020-12-29 |
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,874,674 - Wu , et al. December 29, 2 | 2020-12-29 |
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261453 - WU; Songliang ;   et al. | 2020-08-20 |
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261452 - WU; Songliang ;   et al. | 2020-08-20 |
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200253972 - Kind Code | 2020-08-13 |
Lanosterol prodrug compound and preparation method therefor and use thereof Grant 10,738,076 - Liu , et al. A | 2020-08-11 |
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,668,066 - Wu , et al. | 2020-06-02 |
Ssao Inhibitor App 20200115352 - LUO; Zhi ;   et al. | 2020-04-16 |
Method, Apparatus, And Device For Processing Web Application Package App 20200110593 - Luo; Zhi | 2020-04-09 |
Steroid Derivative FXR Agonist App 20190382437 - HE; Haiying ;   et al. | 2019-12-19 |
Lanosterol Prodrug Compound And Preparation Method Therefor And Use Thereof App 20190256548 - LIU; Yizhi ;   et al. | 2019-08-22 |
Caspase Inhibitor And Pharmaceutical Composition, Use And Therapeutic Method Thereof App 20190135733 - He; Haiying ;   et al. | 2019-05-09 |
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20180235965 - WU; Songliang ;   et al. | 2018-08-23 |